General Information
Version
6.7
Revision date
2025-11-03
Product name
Metronidazole
CAS No.
443-48-1
REACH No
A
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H350, H373
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Germ cell mutagenicity, H340: May cause genetic defects. (Category 1B) Carcinogenicity, (Category 1B) H350: May cause cancer. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2) through prolonged or repeated exposure.
Signal word
Danger Danger
Hazard statements
H340 May cause genetic defects. H350 May cause cancer. H373 May cause damage to organs through prolonged or repeated exposure. H340 May cause genetic defects. H350 May cause cancer.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.
